黄色在线网址无码|精品久久久噜噜噜久久|国产白嫩护士被弄高潮|一级av毛片免费在线观看|国产精品白丝情趣AV网站|亚洲国产成人久久综合电影|亚洲AⅤ秘 无码一区二区三区|久久人人舔人人爽舔人人AV片

      
      

            
            

              Industry Events
              Roche wins FDA approval for novel diabetes Dx
              Time:2013-05-28 11:07:03     Source:3G Biotech     Readers:

              Roche ($RHHBY) won the FDA's blessing to market a hemoglobin-based diabetes diagnostic, the latest advance in testing for the disease and the first assay of its kind approved in the U.S.

              The Tina-quant HbA1cDx assay charts a patient's average blood sugar levels over the past three months by measuring the percentage of hemoglobin A1c bound to glucose. That information allows physicians to better diagnose diabetes and plot its progression as they manage treatment for patients.

              The test works on Roche's Cobas Integra 800 platform, and the FDA's sign-off allows the company to start selling the test to clinical labs, making it first in line to cash in on U.S. demand for HbA1c testing. As the agency points out, there are tests FDA-cleared for diabetes monitoring, but Roche's offering is the first approved for diagnosis.

              On Roche's heels is Abbott Laboratories ($ABT), which won a CE mark earlier this month for an A1c test of its own, used on the company's Architect diagnostic analyzers. Abbott has filed for FDA approval for the test and is in the meantime rolling it out in in countries across Europe, Asia, Latin America and Africa.

              The head start on sales of an in-demand test could well help Roche's flagging diabetes business. While the company's diagnostics arm hauled in $11.2 billion and a 20% share of the global diagnostics market in 2012, Roche has long struggled with pricing pressures and reimbursement cuts for diabetes.

              In October, Roche announced plans to cut 100 jobs in diabetes and shift the business' diagnostics division to its Indianapolis headquarters while moving the glucose monitor unit to Germany. Now, according to a Reuters report, Roche is exploring the idea of unloading the meter business, meeting with potential suitors in early-stage talks.



              Read more: Roche wins FDA approval for novel diabetes Dx - FierceMedicalDevices http://www.fiercemedicaldevices.com/story/roche-wins-fda-approval-novel-diabetes-dx/2013-05-24#ixzz2UYLlSXcn
              Subscribe at FierceMedicalDevices
              會(huì)員登錄:
              如您忘記密碼,請(qǐng)聯(lián)系我們的客服!
              聯(lián)系電話:400-669-0360
              登陸:
              • 新浪微博登錄
              衡山县| 宁晋县| 嘉善县| 娄烦县| 河东区| 西青区| 宣武区| 奉化市| 潍坊市| 正定县| 佛冈县| 禄丰县| 花莲市| 浠水县| 大渡口区| 汕头市| 怀集县| 阿勒泰市| 南阳市| 南康市| 休宁县| 高安市| 军事| 祁东县| 寿光市| 大埔区| 临西县| 惠来县| 临洮县| 陵川县| 泾川县| 大悟县| 张家港市| 江山市| 丹江口市| 琼结县| 衡阳县| 蒙城县| 合作市| 北票市| 平塘县|